Status:
COMPLETED
Autonomous Telephone Follow-up After Cataract Surgery
Lead Sponsor:
University of Plymouth
Collaborating Sponsors:
University of Oxford
Imperial College London
Conditions:
Cataract
After Cataract
Eligibility:
All Genders
Phase:
NA
Brief Summary
This project will apply AI technology to meet the gap between increasing demand and limited capacity of high- volume healthcare services. The project will develop evidence that will support the safe d...
Detailed Description
Background Due to an ageing population and increased expectation, the demand for many services is exceeding the capacity of the clinical workforce. As a result, staff are facing a crisis of burnout f...
Eligibility Criteria
Inclusion
- Willing and able to provide informed consent;
- Aged 18 years or older;
- On the waiting list for routine cataract surgery. Cataract surgery as part of a combined procedure with other ocular surgery will not be included;
- No history or presence of significant ocular comorbidities that would be expected to alter the risks of cataract surgery or normal post-operative follow-up schedule. Note that significant ocular comorbidities do not include stable, chronic, or inactive ocular conditions such as amblyopia, drop-controlled stable glaucoma or ocular hypertension, previous squint surgery, inactive macular pathology, previous refractive surgery, or previous vitreoretinal surgery with stable retina.
Exclusion
- Individuals with any condition that could preclude the ability to comply with the study or follow-up procedures;
- Presence of ocular or systemic uncontrolled disease (unless deemed not clinically significant by the Investigator and Sponsor);
- Involved in current research related to this technology or been involved in related research to this technology prior to recruitment;
- Cognitive difficulties, hearing impairment or non-English speakers;
- History of current or severe, unstable or uncontrolled systemic disease (unless deemed not clinically significant by the Investigator and Sponsor).
Key Trial Info
Start Date :
September 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 24 2022
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT05213390
Start Date
September 17 2021
End Date
March 24 2022
Last Update
January 13 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Healthcare NHS Trust
London, United Kingdom
2
Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom